Nuveen’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-223,410
Closed -$1.67M 3556
2022
Q1
$1.67M Buy
223,410
+150,123
+205% +$1.24M ﹤0.01% 2584
2021
Q4
$988K Sell
73,287
-6,333
-8% -$125K ﹤0.01% 2868
2021
Q3
$2.19M Sell
79,620
-4,372
-5% -$139K ﹤0.01% 2629
2021
Q2
$3.84M Buy
83,992
+12,146
+17% +$574K ﹤0.01% 2378
2021
Q1
$3.16M Buy
71,846
+22,948
+47% +$1.12M ﹤0.01% 2396
2020
Q4
$1.5M Buy
48,898
+2,542
+5% +$80.6K ﹤0.01% 2643
2020
Q3
$1.48M Buy
+46,356
New +$1.14M ﹤0.01% 2505

Other funds holding AMTI

Nuveen's AMTI Position: Q2 2022 in Review

Nuveen sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q2 2022, closing a stake of 223,410 shares — an estimated $1.67M sold.

Nuveen first reported a position in AMTI in Q3 2020 and held it in 7 quarters. The position peaked at $3.84M in Q2 2021. 56 funds tracked by Wall St. Rank hold AMTI as of Q2 2022.

  • Nuveen reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 223,410 Applied Molecular Transport Inc. Common Stock shares in Q2 2022, an estimated $1.67M.
  • Nuveen first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Nuveen's Applied Molecular Transport Inc. Common Stock position peaked at $3.84M in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.